---
title: "ELIAZ ROM E — Ownership Dossier"
canonical: https://whiteintel.dev/entity/286133cb-c2fe-5c24-9ebd-a2054ed3d38a
json: https://whiteintel.dev/api/public/dossier/286133cb-c2fe-5c24-9ebd-a2054ed3d38a
identifier: sec:0001540346
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ELIAZ ROM E

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001540346`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/286133cb-c2fe-5c24-9ebd-a2054ed3d38a  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/286133cb-c2fe-5c24-9ebd-a2054ed3d38a  

## Ownership & control

### Holdings / subsidiaries

- **AVANYX THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/85839920-5280-5e41-aa6c-f50a51dd4a4a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ELIAZ ROM E**. Human view: https://whiteintel.dev/entity/286133cb-c2fe-5c24-9ebd-a2054ed3d38a · Structured JSON: https://whiteintel.dev/api/public/dossier/286133cb-c2fe-5c24-9ebd-a2054ed3d38a._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._